Wasem S, Weichert S, Walther S, Weigl J A, Puppe W, Ihorst G, Schmitt H-J, Forster J
Department of Pediatrics, St. Josefs Hospital, Freiburg, Germany.
Klin Padiatr. 2008 Sep-Oct;220(5):291-5. doi: 10.1055/s-2007-990301. Epub 2007 Dec 20.
This study analyses the pathogens of acute lower respiratory tract infections (LRI) in children in a German community hospital over six years. Against this background the adoption of new diagnostic and therapeutic guidelines for the LRI management and of RSV-cases in particular is studied.
1054 children aged zero to 36 months hospitalized with LRI were prospectively included in the surveillance studies "Parainfluenzavirus (PIV) and Respiratory syncytial virus (RSV) infections in Germany [PRI.de] 1999-2001" and the "pediatric infectious diseases network on acute respiratory tract infections" [PID-ARI.net] for the time period of October 2002 until June 2005. The nasopharyngeal aspirates (NPA) of these children had been analysed for RSV, PIV 1,2,3 and influenzavirus (IV)-A, -B. In 2003/2004 the national guideline on how to diagnose and treat RSV-disease (bronchiolitis) changed. Data on LRI cases severity and especially those regarding the clinical management of RSV-infections were compared to see differences following the release of the guideline.
84% of the children were between zero and 24 months old. 34% of the NPA specimens were positive for RSV, 7.7% for PIV 1,2,3 and 4.7% for IV-A, -B. Epidemiological findings did not differ substantially between the two studies. Clinical management of RSV-LRI, especially drug use, did not change except for the lower rate of x-ray examination (p<0.01).
The spectrum of causing agents in LRI of children remained quite stable over of six years. Diagnostic and therapeutic concepts remain also stable in a situation where new guidelines were introduced, but not reinforced.
本研究分析了一家德国社区医院六年内儿童急性下呼吸道感染(LRI)的病原体。在此背景下,研究了采用新的LRI管理诊断和治疗指南,尤其是呼吸道合胞病毒(RSV)病例的指南。
1054名年龄在0至36个月因LRI住院的儿童被前瞻性纳入2002年10月至2005年6月期间的监测研究“德国副流感病毒(PIV)和呼吸道合胞病毒(RSV)感染[PRI.de]1999 - 2001”以及“急性呼吸道感染儿科传染病网络”[PID - ARI.net]。对这些儿童的鼻咽抽吸物(NPA)进行了RSV、PIV 1、2、3和甲型、乙型流感病毒(IV)分析。2003/2004年,关于如何诊断和治疗RSV疾病(细支气管炎)的国家指南发生了变化。比较了LRI病例严重程度的数据,尤其是RSV感染临床管理的数据,以观察指南发布后的差异。
84%的儿童年龄在0至24个月之间。34%的NPA标本RSV呈阳性,7.7%的PIV 1、2、3呈阳性,4.7%的甲型、乙型流感病毒呈阳性。两项研究的流行病学结果没有实质性差异。RSV - LRI的临床管理,尤其是药物使用,除了X线检查率较低外(p<0.01)没有变化。
六年内儿童LRI的致病原谱保持相当稳定。在引入新指南但未强化的情况下,诊断和治疗概念也保持稳定。